Entity A had $9,800,000 of capitalised development expenditure at cost brought forward on 1 October 2020 in respect of products currently in production and a new project began on the same date. The research stage of the new project lasted until 31 December 2020 and incurred $556,000 of costs. From that date, the project incurred development costs of $256,000 per month. On 1 April 2021, the directors became confident that the project would be successful and yield a profit well in excess of costs. The project was still in development on 30 September 2021. Capitalised development expenditure is amortised using the straight-line method. The useful life is estimated at 25 years. REQUIRED: Measure the amount that will be charged to Statement of Profit or Loss for the year ended 30 September 2021 in respect of research and development costs.
Entity A had $9,800,000 of capitalised development expenditure at cost brought forward on 1 October 2020 in respect of products currently in production and a new project began on the same date.
The research stage of the new project lasted until 31 December 2020 and incurred $556,000 of costs.
From that date, the project incurred development costs of $256,000 per month.
On 1 April 2021, the directors became confident that the project would be successful and yield a profit well in excess of costs. The project was still in development on 30 September 2021.
Capitalised development expenditure is amortised using the straight-line method. The useful life is estimated at 25 years.
REQUIRED:
Measure the amount that will be charged to Statement of Profit or Loss for the year ended 30 September 2021 in respect of research and development costs.
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
